参考文献/References:
[1] 陈仲波,朱笕青.卵巢癌筛查的研究进展[J].中国现代医生,2016,54(35):164-168. CHEN Zhongbo,ZHU Jianqing.Research progress of ovarian cancer screeing[J].China Modern Doctor,2016,54(35):164-168.
[2] 刘平.miR-135b在宫颈癌中的表达及临床意义[J].河南科技大学学报(医学版),2016,34(3):177-179. LIU Ping.Experssion and its clinical significance of miR-135b in cervical cancer[J].J Henan Univ Sci Tech(Med Sci),2016,34(3):177-179.
[3] 乐珍,沈君菁,黄启涛,等.miR-135b通过靶向F-OXO1促进子宫内膜癌细胞的增殖[J].南方医科大学学报,2016,36(5):675-680. YUE Zhen,SHEN Junjing,HUANG Qitao,et al.Mi-R-135b promotes proliferation of endometrial carcinoma cells by targeting FOXO1[J].J South Med Univ,2016,36(5):675-680.
[4] LI Yan,XU Dan,BAO Chun-yang,et al.MicroRNA-135b,a HSF1 target,promotes tumor invasion and metastasis by regulating RECK and EVI5 in hepatocellular carcinoma[J].Oncotarget,2015,6(4):2421-2433.
[5] HUNTZINGER E,IZAURRALDE E.Gene silencing by micro NAs:contributions oftranslational repression and mRNA decay[J].Nat Rev Genet,2011,12(2):99-110.
[6] BARTEL D P.MicroRNAs:genomics,biogenesis,me-chanism,and function[J].Cell,2004,116(2):281-297.
[7] PASQUINELLI A E.MicroRNAs and their targets:recognition, regulation and an emerging reciprocal relationship[J].Nat Rev Genet,2012,13(4):271-282.
[8] LIU Zhaojian, LIU Jinsong, SEGURA M F,et al.MiR-182 overexpression intumourigenesis of high-grade serous ovarian carcinoma[J].The Journal of Pathology,2012,228(2):204-215.
[9] HUYNH C,SEGURA M F,GAZIEL-SOVRAN A,et al.Efficient in vivo microRNA targeting of liver metastasis[J].Oncogene,2011,30(12):1481-1488.
[10] CHENG Weiwei,LIU Te,WAN Xiaoping,et al.MicroRNA-199a targets CD44 to suppress the tumorigenicity and multidrug resistance of ovarian cancer-initiating cells[J].FEBS Journal,2012,279(11):2047-2059.
[11] COFFRE M,KORALOV S B.miRNAs in B cell development and lymphomagenesis[J].Trends Mol Med,2017,23(8):721-736.
[12] SMITH A,TEKNOS T N,PAN Q.Epithelial to me-senchymal transition inhead and neck squamous cell carcinoma[J].Oral Oncol,2013,49(4):287-292.
[13] SATO R,SEMBA T,SAYA H,et al.Concise review:Stem cells and epithelial -mesenchymal transition in cancer:Biological implicationgs and therapeutic targets[J].Stem Cells,2016,34(8):1997-2007.
[14] HUANG Jing,LI Hongzhong,REN Guosheng.Epithelial-mesenchymal transition and drug resistance in breast cancer(review)[J].Int J Oncol,2015,47(3):840-848.
相似文献/References:
[1]顾益凤,朱自力,张金业,等.利用ROC曲线选择血清HE-4对卵巢癌的最佳诊断界点[J].现代检验医学杂志,2015,30(04):141.[doi:10.3969/j.issn.1671-7414.2015.04.043]
GU Yi-feng,ZHU Zi-li,ZHANG Jin-ye,et al.Selecting the Best Cut-off Point
of Serum HE-4 in Ovarian Cancer by ROC Curve[J].Journal of Modern Laboratory Medicine,2015,30(02):141.[doi:10.3969/j.issn.1671-7414.2015.04.043]
[2]郑福利,张颖,王建.血清S100A6检测对卵巢上皮性癌的诊断价值[J].现代检验医学杂志,2015,30(05):22.[doi:10.3969/j.issn.1671-7414.2015.05.007]
ZHENG Fu-li,ZHANG Ying,WANG Jian.Study on Diagnostic Value of Detecting Serum S100A6
in the Epithelial Ovarian Carcinoma[J].Journal of Modern Laboratory Medicine,2015,30(02):22.[doi:10.3969/j.issn.1671-7414.2015.05.007]
[3]詹颉,常宁宁,李小侠,等.CEA,AFP,CA125,CA199和CA72-4联合检测在鉴别卵巢良恶性疾病中的应用价值[J].现代检验医学杂志,2015,30(05):50.[doi:10.3969/j.issn.1671-7414.2015.05.015]
ZHAN Jie,CHANG Ning-ning,LI Xiao-xia,et al.Clinical Value of Combined Detection of CEA,AFP,CA125,CA199 and
CA72-4 in the Identification of Ovarian Benign and Malignant Disease[J].Journal of Modern Laboratory Medicine,2015,30(02):50.[doi:10.3969/j.issn.1671-7414.2015.05.015]
[4]邢瑞青,吴永昌,陈慧昱,等.血清CA125,HE4及ROMA指数对卵巢癌诊断价值的临床研究[J].现代检验医学杂志,2016,31(06):37.[doi:10.3969/j.issn.1671-7414.2016.06.010]
XING Rui-qing,WU Yong-chang,CHEN Hui-yu,et al.Diagnostic Value of Serum CA125,HE4 and ROMA Index in Patients with Ovarian Cancer[J].Journal of Modern Laboratory Medicine,2016,31(02):37.[doi:10.3969/j.issn.1671-7414.2016.06.010]
[5]张 悦a,段海霞,暴 蕾a,等.microRNA-125b在葛根素诱导人卵巢癌细胞SKOV3凋亡中的作用研究[J].现代检验医学杂志,2017,32(05):13.[doi:10.3969/j.issn.1671-7414.2017.05.004]
ZHANG Yuea,DUAN Hai-xia,BAO Leia,et al.Role of MicroRNA-125b in Human Ovarian Cancer Cell
SKOV3 Induced Apoptosis by Puerarin[J].Journal of Modern Laboratory Medicine,2017,32(02):13.[doi:10.3969/j.issn.1671-7414.2017.05.004]
[6]徐金良a,杜丹丹,翟志敏,等.卵巢良恶性肿瘤患者血液NLR,LMR,RDW,PLR四项参数的变化及其临床意义[J].现代检验医学杂志,2018,33(02):16.[doi:10.3969/j.issn.1671-7414.2018.02.001]
XU Jin-lianga,DU Dan-dan,ZHAI Zhi-min,et al.Changes and Clinical Significance of Four Parameters of NLR,LMR,
RDW and PLR in Patients with Benign and Malignant Ovarian Tumors[J].Journal of Modern Laboratory Medicine,2018,33(02):16.[doi:10.3969/j.issn.1671-7414.2018.02.001]
[7]马同敏,赵志强.血清CA125,STIP1和IGF-Ⅰ联合检测对卵巢癌的早期诊断价值研究[J].现代检验医学杂志,2018,33(06):50.[doi:10.3969/j.issn.1671-7414.2018.06.013]
MA Tong-min,ZHAO Zhi-qiang.Clinical Value of Combined Detection of Serum CA125,STIP1 and IGF-I Levels in Early Diagnosis of Ovarian Cancer[J].Journal of Modern Laboratory Medicine,2018,33(02):50.[doi:10.3969/j.issn.1671-7414.2018.06.013]
[8]张善弟,荆成宝,禹 梅.血清CEA,CA125和HE4联合检测对卵巢癌的诊断价值[J].现代检验医学杂志,2018,33(06):122.[doi:10.3969/j.issn.1671-7414.2018.06.032]
ZHANG Shan-di,JING Cheng-bao,YU Mei.Clinical Value of Combined Detection of Serum CEA,CA125 and HE4 in the Diagnosis of Ovarian Cancer[J].Journal of Modern Laboratory Medicine,2018,33(02):122.[doi:10.3969/j.issn.1671-7414.2018.06.032]
[9]侯 娟,蒋树立,滕长财.基于TCGA 数据库卵巢癌患者的miR-301b 表达量与生存状况生物信息学分析[J].现代检验医学杂志,2020,35(04):37.[doi:10.3969/j.issn.1671-7414.2020.04.009]
HOU Juan,JIANG Shu-li,TENG Chang-cai.Bioinformatics Analysis of Mir-301b Expression and Survival Status of Patients with Ovarian Cancer Based on TCGA Database[J].Journal of Modern Laboratory Medicine,2020,35(02):37.[doi:10.3969/j.issn.1671-7414.2020.04.009]
[10]杨立芬,何建清,尹立新,等.人卵巢癌细胞SKOV3中壳多糖酶3样蛋白1的表达和对细胞增殖及侵袭的影响实验研究[J].现代检验医学杂志,2021,36(04):31.[doi:10.3969/j.issn.1671-7414.2021.04.007]
YANG Li-fen,HE Jian-qing,YIN Li-xin,et al.Expression of Chitinase 3-like Protein 1 in Human Ovarian Cancer Cell Skov3and Its Effect on Cell Proliferation and Invasion[J].Journal of Modern Laboratory Medicine,2021,36(02):31.[doi:10.3969/j.issn.1671-7414.2021.04.007]